Constant molecular aging rates vs. the exponential acceleration of mortality

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 5, 2016, Pages 1121-1123

  Finch, Caleb E ^a   Crimmins, Eileen M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ACCELERATION; AGING; HIGH RISK POPULATION; HUMAN; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; NONHUMAN; NOTE; PRIORITY JOURNAL; SENESCENCE; ANIMAL; METABOLISM;

AGING; ANIMALS; PROTEINS;

EID: 84957899945     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1524017113     Document Type: Note

References (17)

1. Gorisse L, et al. (2016) Protein carbamylation is a hallmark of aging. Proc Natl Acad Sci USA 113:1191-1196.
2. Stark GR, Stein WH, Moore S (1960) Reactions of the cyanate present in aqueous urea with amino acids and proteins. J Biol Chem 235(11):3177-3181.
3. Hawkins CL (2014) Role of cyanate in the induction of vascular dysfunction during uremia: More than protein carbamylation? Kidney Int 86(5):875-877.
4. Sell DR, et al. (1996) Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci USA 93(1):485-490.
5. Sell DR, et al. (2005) Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 280(13): 12310-12315.
6. Hannum G, et al. (2013) Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 49(2):359-367.
7. Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14(10):R115.
8. Rönn T, Ling C (2015) DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes. Epigenomics 7(3):451-460.
9. Thomas MC, et al.; ADVANCE Collaborative Group (2015) Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes. Diabetes Care 38(10):1891-1897.
10. Finch CE, Crimmins EM (2004) Inflammatory exposure and historical changes in human life-spans. Science 305(5691):1736-1739.
11. Robine JM (2011) Age patterns of adult mortality. International Handbook of Adult Mortality, eds Rogers R, Crimmins E (Springer, Dordrecht, The Netherlands), pp 207-226.
12. Beltrán-Sáncheza H, Crimmins E, Finch C (2012) Early cohort mortality predicts the rate of aging in the cohort: A historical analysis. J Dev Orig Health Dis 3(5): 380-386.
13. Finch CE, Beltrán-Sánchez H, Crimmins EM (2014) Uneven futures of human lifespans: Reckonings from Gompertz mortality rates, climate change, and air pollution. Gerontology 60(2):183-188.
14. Missov TI, Vaupel JW (2015) Mortality implication of mortality plateaus. SIAM Rev 57(1):61-70.
15. Hajjar I, Kotchen JM, Kotchen TA (2006) Hypertension: Trends in prevalence, incidence, and control. Annu Rev Public Health 27:465-490.
16. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903-1913.
17. De Waal EM, et al. (2013) Elevated protein carbonylation and oxidative stress do not affect protein structure and function in the long-living naked-mole rat: A proteomic approach. Biochem Biophys Res Commun 434(4):815-819.